| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |